Potential Role of Sugar Transporters in Cancer and Their Relationship with Anticancer Therapy

Sugars, primarily glucose and fructose, are the main energy source of cells. Because of their hydrophilic nature, cells use a number of transporter proteins to introduce sugars through their plasma membrane. Cancer cells are well known to display an enhanced sugar uptake and consumption. In fact, sugar transporters are deregulated in cancer cells so they incorporate higher amounts of sugar than normal cells. In this paper, we compile the most significant data available about biochemical and biological properties of sugar transporters in normal tissues and we review the available information about sugar carrier expression in different types of cancer. Moreover, we describe the possible pharmacological interactions between drugs currently used in anticancer therapy and the expression or function of facilitative sugar transporters. Finally, we also go into the insights about the future design of drugs targeted against sugar utilization in cancer cells.

[1]  D. Bentrem,et al.  Apigenin Inhibits the GLUT-1 Glucose Transporter and the Phosphoinositide 3-Kinase/Akt Pathway in Human Pancreatic Cancer Cells , 2008, Pancreas.

[2]  F. Ismail-Beigi,et al.  Dual Control of glut1 Glucose Transporter Gene Expression by Hypoxia and by Inhibition of Oxidative Phosphorylation* , 1997, The Journal of Biological Chemistry.

[3]  H. Pelicano,et al.  Glycolysis inhibition for anticancer treatment , 2006, Oncogene.

[4]  H. Minn,et al.  Expression of glucose transporters in head‐and‐neck tumors , 1994, International journal of cancer.

[5]  K. Black,et al.  Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors. , 1994, Brain research. Molecular brain research.

[6]  D. Bowden,et al.  Differential expression of glucose transporters in normal and pathologic thyroid tissue. , 2004, Thyroid : official journal of the American Thyroid Association.

[7]  Peter Bartenstein,et al.  Overexpression of Glut‐1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma , 2003, Cancer.

[8]  N. Kohno,et al.  SGLT Gene Expression in Primary Lung Cancers and Their Metastatic Lesions , 2001, Japanese journal of cancer research : Gann.

[9]  R. Brown,et al.  GLUT1 expression in human breast carcinoma: correlation with known prognostic markers. , 1995, Anticancer research.

[10]  D. Malide,et al.  The facilitative glucose transporter GLUT3: 20 years of distinction. , 2008, American journal of physiology. Endocrinology and metabolism.

[11]  D. Burstein,et al.  GLUT1 glucose transporter expression in colorectal carcinoma , 1998, Cancer.

[12]  R L Wahl,et al.  An Immunohistochemical Study , 2006 .

[13]  D. James,et al.  Developmental expression of insulin-regulatable glucose transporter GLUT-4. , 1992, The American journal of physiology.

[14]  M. Hung,et al.  Survival of cancer cells is maintained by EGFR independent of its kinase activity. , 2008, Cancer cell.

[15]  A. Schürmann,et al.  The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function. , 2004, JPEN. Journal of parenteral and enteral nutrition.

[16]  Joanne I. Yeh,et al.  Association study of genetic polymorphisms of SLC2A10 gene and type 2 diabetes in the Taiwanese population , 2006, Diabetologia.

[17]  M. Carrasco,et al.  Differential subcellular distribution of glucose transporters GLUT1–6 and GLUT9 in human cancer: Ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues , 2006, Journal of cellular physiology.

[18]  Christophe Magnan,et al.  mTOR Inhibition by Rapamycin Prevents β-Cell Adaptation to Hyperglycemia and Exacerbates the Metabolic State in Type 2 Diabetes , 2008, Diabetes.

[19]  H. Yamaguchi,et al.  Expression of glucose transporter 5 by microglia in human gliomas , 2004, Neuropathology and applied neurobiology.

[20]  J. Best,et al.  Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer , 2005, Journal of cellular physiology.

[21]  H. Lodish,et al.  Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. , 1987, Science.

[22]  R. Airley,et al.  Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma? , 2003, British Journal of Cancer.

[23]  A. Klip,et al.  Exercise induces recruitment of the "insulin-responsive glucose transporter". Evidence for distinct intracellular insulin- and exercise-recruitable transporter pools in skeletal muscle. , 1990, The Journal of biological chemistry.

[24]  E. Horton,et al.  Identification of an intracellular pool of glucose transporters from basal and insulin-stimulated rat skeletal muscle. , 1990, The Journal of biological chemistry.

[25]  U. Tateishi,et al.  Prognostic implications of glucose transporter protein-1 (glut-1) overexpression in bone and soft-tissue sarcomas. , 2007, Japanese journal of clinical oncology.

[26]  H. Dietz,et al.  Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome , 2006, Nature Genetics.

[27]  K. Kinzler,et al.  Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells , 2009, Science.

[28]  M. Graham,et al.  Deoxyglucose Kinetics in a Rat Brain Tumor , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  C. Runowicz,et al.  GLUT1 and GLUT8 in endometrium and endometrial adenocarcinoma , 2006, Modern Pathology.

[30]  K. Fung,et al.  Inhibition of cell proliferation in human breast tumor cells by antisense oligonucleotides against facilitative glucose transporter 5 , 2004, Journal of cellular biochemistry.

[31]  P. Pedersen,et al.  Intracellular localization and properties of particulate hexokinase in the Novikoff ascites tumor. Evidence for an outer mitochondrial membrane location. , 1983, The Journal of biological chemistry.

[32]  I. S. Wood,et al.  Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins , 2003, British Journal of Nutrition.

[33]  V. Ganapathy,et al.  Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. , 2009, Pharmacology & therapeutics.

[34]  K. Moley,et al.  GLUT8 Contains a [DE]XXXL[LI] Sorting Motif and Localizes to a Late Endosomal/Lysosomal Compartment , 2005, Traffic.

[35]  T. Oguri,et al.  Differential Expression of Facilitative Glucose Transporter (GLUT) Genes in Primary Lung Cancers and Their Liver Metastases , 1999, Japanese journal of cancer research : Gann.

[36]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[37]  A. Klip,et al.  Recruitment of GLUT-4 glucose transporters by insulin in diabetic rat skeletal muscle. , 1990, Biochemical and biophysical research communications.

[38]  Y. Kikuchi,et al.  Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. , 2008, American journal of human genetics.

[39]  A. Mobasheri,et al.  HUMAN ARTICULAR CHONDROCYTES EXPRESS THREE FACILITATIVE GLUCOSE TRANSPORTER ISOFORMS: GLUT1, GLUT3 AND GLUT9 , 2002, Cell biology international.

[40]  Youn Wha Kim,et al.  Expression of the GLUT1 glucose transporter and p53 in carcinomas of the pancreatobiliary tract. , 2010, Pathology, research and practice.

[41]  C. Dang,et al.  Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc* , 2000, The Journal of Biological Chemistry.

[42]  J. Corbett,et al.  Facilitative glucose transporter 9 expression affects glucose sensing in pancreatic beta-cells. , 2009, Endocrinology.

[43]  D. Yin,et al.  Hexose transporter mRNAs for GLUT4, GLUT5, and GLUT12 predominate in human muscle. , 2006, American journal of physiology. Endocrinology and metabolism.

[44]  R. Shigemoto,et al.  Distribution of the glucose transporters in human brain tumors. , 1992, Cancer research.

[45]  K. Grankvist,et al.  Glucose transporter‐1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor‐1α , 2007, BJU international.

[46]  J. Moley,et al.  Identification and Characterization of Human Glucose Transporter-like Protein-9 (GLUT9) , 2004, Journal of Biological Chemistry.

[47]  O. Warburg.  On the origin of cancer cells. , 1956, Science.

[48]  K. Moley,et al.  Facilitative glucose transporter 9, a unique hexose and urate transporter. , 2009, American journal of physiology. Endocrinology and metabolism.

[49]  H. Freeze,et al.  GLUT14, a duplicon of GLUT3, is specifically expressed in testis as alternative splice forms. , 2002, Genomics.

[50]  L. Aicher,et al.  The tuberous sclerosis complex regulates trafficking of glucose transporters and glucose uptake. , 2008, The American journal of pathology.

[51]  P. Pauwels,et al.  Expression of SGLT1, Bcl-2 and p53 in Primary Pancreatic Cancer Related to Survival , 2008, Cancer investigation.

[52]  J. Stevenson,et al.  Expression of GLUT12 in the fetal membranes of the human placenta. , 2005, Placenta.

[53]  J. Best,et al.  Differential expression of GLUT12 in breast cancer and normal breast tissue. , 2003, Cancer letters.

[54]  J. Berger,et al.  Decreased expression of the insulin-responsive glucose transporter in diabetes and fasting , 1989, Nature.

[55]  B. Ebert,et al.  Hypoxia and Mitochondrial Inhibitors Regulate Expression of Glucose Transporter-1 via Distinct Cis-acting Sequences (*) , 1995, The Journal of Biological Chemistry.

[56]  A. Zorzano,et al.  Insulin-regulated glucose uptake in rat adipocytes is mediated by two transporter isoforms present in at least two vesicle populations. , 1989, The Journal of biological chemistry.

[57]  Chi V Dang,et al.  Cancer's molecular sweet tooth and the Warburg effect. , 2006, Cancer research.

[58]  A. Blais.  Expression of Na(+)-coupled sugar transport in HT-29 cells: modulation by glucose. , 1991, The American journal of physiology.

[59]  M. Mozzoli,et al.  Glucose Transporter Proteins in Human Insulinoma , 1994, Annals of Internal Medicine.

[60]  K. Haruma,et al.  Clinical Significance of Human Erythrocyte Glucose Transporter 1 Expression at the Deepest Invasive Site of Advanced Colorectal Carcinoma , 2001, Oncology.

[61]  T. Hansen,et al.  Genetic variation of the GLUT10 glucose transporter (SLC2A10) and relationships to type 2 diabetes and intermediary traits. , 2003, Diabetes.

[62]  D. James,et al.  Identification of a novel glucose transporter-like protein-GLUT-12. , 2002, American journal of physiology. Endocrinology and metabolism.

[63]  J. Chatton,et al.  Identification of a mammalian H+‐myo‐inositol symporter expressed predominantly in the brain , 2001, The EMBO journal.

[64]  M. Tokuda,et al.  Growth inhibition of head and neck carcinomas by D‐allose , 2009, Head & neck.

[65]  B. Thorens,et al.  Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy , 2009, Proceedings of the National Academy of Sciences.

[66]  A. Schürmann,et al.  GLUT8, the enigmatic intracellular hexose transporter. , 2009, American journal of physiology. Endocrinology and metabolism.

[67]  J. Tavaré,et al.  An intracellular motif of GLUT4 regulates fusion of GLUT4-containing vesicles , 2008, BMC Cell Biology.

[68]  A. Schürmann,et al.  Essential role of glucose transporter GLUT3 for post-implantation embryonic development , 2008, The Journal of endocrinology.

[69]  M. Armoni,et al.  The Tumor Suppressor p53 Down-Regulates Glucose Transporters GLUT1 and GLUT4 Gene Expression , 2004, Cancer Research.

[70]  Mark A. Stephenson,et al.  Overexpression of glut1 and glut3 in stage I nonsmall cell lung carcinoma is Associated with poor survival , 1997, Cancer.

[71]  J. Baselga,et al.  Expression of the fructose transporter GLUT5 in human breast cancer. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[72]  M. Minden,et al.  A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death , 2008, Molecular Cancer Therapeutics.

[73]  D. Bowden,et al.  Differential expression of facilitative glucose transporters in normal and tumour kidney tissues , 2007, BJU international.

[74]  M. Sitbon,et al.  Erythroid glucose transporters , 2009, Current opinion in hematology.

[75]  L. Truong,et al.  Expression of GLUT1 in primary renal tumors: morphologic and biologic implications. , 2007, American journal of clinical pathology.

[76]  Erika Zambello,et al.  Evaluation of expression and function of the H+/myo-inositol transporter HMIT , 2009, BMC Cell Biology.

[77]  J. L. Bento,et al.  Genetic analysis of the GLUT10 glucose transporter (SLC2A10) polymorphisms in Caucasian American type 2 diabetes , 2005, BMC Medical Genetics.

[78]  N. Moriyama,et al.  Disease activity and 18F-FDG uptake in organising pneumonia: semi-quantitative evaluation using computed tomography and positron emission tomography , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[79]  N. Savaraj,et al.  2-Deoxy-d-glucose Increases the Efficacy of Adriamycin and Paclitaxel in Human Osteosarcoma and Non-Small Cell Lung Cancers In Vivo , 2004, Cancer Research.

[80]  S. Gullans,et al.  Differential gene expression profiling in human brain tumors. , 2001, Physiological genomics.

[81]  D. James,et al.  Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein , 1988, Nature.

[82]  P. Bannasch,et al.  Expression of facilitative glucose transport proteins during development of squamous cell carcinomas of the head and neck , 1999, International journal of cancer.

[83]  D. Yin,et al.  Insulin-stimulated translocation of glucose transporter (GLUT) 12 parallels that of GLUT4 in normal muscle. , 2009, The Journal of clinical endocrinology and metabolism.

[84]  E. Williams,et al.  Expression and localization of GLUT1 and GLUT12 in prostate carcinoma , 2003, Cancer.

[85]  M. Uldry,et al.  The SLC2 family of facilitated hexose and polyol transporters , 2004, Pflügers Archiv.

[86]  K. Isselbacher.  Sugar and amino acid transport by cells in culture--differences between normal and malignant cells. , 1972, The New England journal of medicine.

[87]  P. Dawson,et al.  Sequence and functional analysis of GLUT10: a glucose transporter in the Type 2 diabetes-linked region of chromosome 20q12-13.1. , 2001, Molecular genetics and metabolism.

[88]  Qiulian Wu,et al.  Expression of Glucose Transporter-1 and -3 in the Head and Neck Carcinoma – The Correlation of the Expression with the Biological Behaviors , 2008, ORL.

[89]  T. Sugino,et al.  Expression of glucose transporter‐1 in human gastric carcinoma , 2001, Cancer.

[90]  C. Thompson,et al.  Differential effects of rapamycin on mammalian target of rapamycin signaling functions in mammalian cells. , 2003, Cancer research.

[91]  Y. Mitsumoto,et al.  Differential expression of the GLUT1 and GLUT4 glucose transporters during differentiation of L6 muscle cells. , 1991, Biochemical and biophysical research communications.

[92]  I. Mellinghoff,et al.  Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer , 2006, Nature Medicine.

[93]  S. Bandinelli,et al.  The GLUT9 Gene Is Associated with Serum Uric Acid Levels in Sardinia and Chianti Cohorts , 2007, PLoS genetics.

[94]  C. Cheeseman,et al.  Characterization of the human SLC2A11 (GLUT11) gene: alternative promoter usage, function, expression, and subcellular distribution of three isoforms, and lack of mouse orthologue , 2005, Molecular membrane biology.

[95]  C. Cheeseman.  GLUT7: a new intestinal facilitated hexose transporter. , 2008, American journal of physiology. Endocrinology and metabolism.

[96]  R. Ferraris,et al.  Regulation of the fructose transporter GLUT5 in health and disease. , 2008, American journal of physiology. Endocrinology and metabolism.

[97]  P. Kellokumpu-Lehtinen,et al.  Tumor localization with18F-2-fluoro-2-deoxy-D-glucose: Comparative autoradiography, glucose 6-phosphatase histochemistry, and histology of renally implanted sarcoma of the rat , 1985, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

[98]  F. Collins,et al.  Evaluation of SLC2A10 (GLUT10) as a candidate gene for type 2 diabetes and related traits in Finns. , 2005, Molecular genetics and metabolism.

[99]  S. Ashley,et al.  Glucose transporter-1 gene expression is associated with pancreatic cancer invasiveness and MMP-2 activity. , 2004, Surgery.

[100]  T. Hansen,et al.  Studies of relationships between the GLUT10 Ala206Thr polymorphism and impaired insulin secretion , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[101]  B. Kahn.  Alterations in glucose transporter expression and function in diabetes: Mechanisms for insulin resistance , 1992, Journal of cellular biochemistry.